Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2017Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational studyYen, C; Sharma, R; Rimassa, L; Arizumi, T; Bettinger, D, et al
1-Sep-2016The ALBI grade provides objective hepatic reserve phenotyping across each BCLC stage of hepatocellular carcinoma.Pinato, DJ; Sharma, R; Yen, C; Arizumi, T; Kubota, K, et al
24-Jan-2017The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug developmentPinato, DJ; Yen, C; Bettinger, D; Ramaswami, R; Arizumi, T, et al
2-Mar-2017On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective studyHowell, J; Pinato, DJ; Ramaswami, R; Bettinger, D; Arizumi, T, et al